We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Smart Fibers Could Allow T-Shirts to Analyze Electrolytes and Metabolites in Sweat

By LabMedica International staff writers
Posted on 23 Jan 2023
Image: The microelectronic fibers fabricated by the thermal drawing process and its fabrics for sweat sensing (Photo courtesy of Jingxuan Wu et al)
Image: The microelectronic fibers fabricated by the thermal drawing process and its fabrics for sweat sensing (Photo courtesy of Jingxuan Wu et al)

Fibers and fabrics have become an integral part of our daily lives, although much remains unchanged for them despite centuries of human progression. Nevertheless, recent advancements in the multi-material fiber drawing process have led to the development of new multifunctional, fiber-based smart fabrics. Smart fabrics make it possible to seamlessly integrate electronics, optics, biosensors, and mechanics into a thin strand of fiber that is intrinsically flexible and as thin as the human hair. Such fabrics can then be used for monitoring the vital physiological signals related to human mental and physical health.

Now, a team of researchers at Tohoku University (Sendai, Japan) has developed a microelectronic fiber with microscopic parameters that is capable of analyzing electrolytes and metabolites in sweat. The micrometer scale of the microelectronic fiber enables it to be woven into clothes for healthcare applications. The researchers developed the microelectronic fiber by leveraging the versatile thermal drawing process, in which heat is applied to draw out micro-structured fiber from its macroscopic preform. The researchers also patterned on two sensing electrodes for sodium and uric acid on the longitudinal surface of the fiber.

Mainstream photolithography and printing technology have made wearable electronics possible, although this generally requires the attachment of fairly rigid electronic patches to the existing fabrics or directly on the skin, resulting in just a small area of the body being covered. The new microelectronic fiber could pave the way for fiber-based smart clothes that offer more versatility in terms of functions, larger sensing areas, and greater comfort. The new smart fabric could revolutionize the textile and healthcare industries, according to the researchers, benefiting the overall society.

"Our breakthrough is the first successful attempt at using thermally drawn fiber in wearable bioelectronics for monitoring biochemical signatures," said Dr. Yuanyuan Guo, assistant professor at Tohoku University's Frontier Research Institute for Interdisciplinary Sciences, who led the research team.

Related Links:
Tohoku University 

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Manual Pipetting Aid
Pipette Controllers macro
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test

Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more